U.S. Markets close in 4 hrs 29 mins

DexCom Reports Second Quarter 2018 Financial Results

SAN DIEGO--(BUSINESS WIRE)--

DexCom, Inc. (DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.

Second Quarter 2018 Highlights:

  • Revenue grew 42% to $242.5 million versus the same quarter of the prior year
  • US revenue grew 35% versus the same quarter of the prior year
  • International revenue grew 78% on a reported basis versus the same quarter of the prior year
  • GAAP net income of $30.2 million, or $0.34 per share
  • Non-GAAP net loss of $9.2 million, or $0.10 loss per share

“Q2 was a fantastic quarter for DexCom and demonstrates that CGM adoption is increasing significantly,” said Kevin Sayer, DexCom’s President and CEO. “This performance was particularly notable considering we only began launching our revolutionary G6 platform late in the quarter, and we are pleased to be able to raise our full year growth outlook.”

Second Quarter 2018 Financial Results:

Revenue was $242.5 million for the second quarter of 2018, an increase of 42% from the $170.6 million in revenue for the same quarter of 2017. Gross profit totaled $153.6 million or 63% of revenue for the second quarter of 2018 compared to a gross profit of $117.5 million or 69% of revenue for the same quarter of 2017.

GAAP net income was $30.2 million, or $0.34 per share, for the second quarter of 2018 compared to GAAP net income of $2.9 million, or $0.03 per share, for the same quarter of 2017.

Non-GAAP net loss was $9.2 million, or $0.10 loss per share, for the second quarter of 2018, which excludes $42.7 million of income related to investments and $3.3 million of non-cash interest expense related to our senior convertible notes. See the table below entitled “Itemized Reconciliation Between GAAP and Non-GAAP Net Income (Loss) and Net Income (Loss) per Share” for a reconciliation of these GAAP and Non-GAAP financial measures.

As of June 30, 2018, DexCom had $606.1 million in cash, cash equivalents and short-term marketable securities.

2018 Annual Guidance:

DexCom updated its projections for the full year 2018:

  • Revenue of approximately $925 million, versus a prior range of $850 million to $860 million
  • Gross profit margin of approximately 64%, versus the prior range of 65% to 68%
  • GAAP operating expenses, excluding investments into non-intensive programs, to grow approximately 14% versus 2017, versus a prior forecast of 10%.

Conference Call

Management will hold a conference call today starting at 4:30 p.m. (Eastern Time). The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to “About Us,” then “Investor Relations,” and then “Events and Presentations,” and will be archived for future reference. To listen to the conference call, please dial (888) 895-5479 (US/Canada) or (847) 619-6250 (International) and use the confirmation number “46267193” approximately five minutes prior to the start time.

Statement regarding use of non-GAAP financial measures

DexCom reports non-GAAP results for net loss and net loss per basic and diluted share in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Our financial measures under GAAP include non-cash interest expense related to our senior convertible notes, non-cash deferred tax benefits related to our senior convertible notes and income related to our equity investment in Tandem Diabetes Care, Inc. as listed in the itemized reconciliation between GAAP and non-GAAP financial measures included in this press release. Management believes that presentation of operating results that excludes these items provides useful supplemental information to investors and facilitates the analysis of our core operating results and comparison of operating results across reporting periods. Management also believes that this supplemental non-GAAP information is therefore useful to investors in analyzing and assessing our past and future operating performance.

These non-GAAP measures may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. We believe that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with U.S. GAAP and that these measures should only be used to evaluate our results of operations in conjunction with the corresponding GAAP measures. We encourage investors to carefully consider our results under GAAP, as well as its supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for use by people with diabetes and by healthcare providers.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that are not purely historical regarding DexCom’s or its management’s intentions, beliefs, expectations and strategies for the future. All forward-looking statements and reasons why results might differ included in this press release are made as of the date of this release, based on information currently available to DexCom, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that may cause actual results to differ materially from DexCom’s current expectations are more fully described in DexCom’s quarterly report on Form 10-Q for the period ended June 30, 2018, as filed with the Securities and Exchange Commission on August 1, 2018. Except as required by law, DexCom assumes no obligation to update any such forward-looking statement after the date of this report or to conform these forward-looking statements to actual results.

DexCom, Inc.
Consolidated Balance Sheets
(In millions—except par value data)
 
  June 30, 2018   December 31, 2017
(Unaudited)  
Assets
Current assets:
Cash and cash equivalents $ 300.2 $ 441.5
Short-term marketable securities 305.9 107.1
Accounts receivable, net 162.0 134.3
Inventory 46.2 45.2
Prepaid and other current assets   21.7     16.6  
Total current assets 836.0 744.7
Property and equipment, net 156.8 145.6
Goodwill 11.9 12.1
Other assets   2.8     1.7  
Total assets $ 1,007.5   $ 904.1  
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities $ 117.9 $ 87.2
Accrued payroll and related expenses 46.1 48.5
Deferred revenue   6.8     3.2  
Total current liabilities 170.8 138.9
Other liabilities 19.6 18.2
Long term senior convertible notes   335.0     327.6  
Total liabilities 525.4 484.7
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 5.0 shares authorized; no shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively

Common stock, $0.001 par value, 200.0 authorized; 88.7 and 88.4 issued and outstanding, respectively, at June 30, 2018; and 87.3 and 87.0 shares issued and outstanding, respectively, at December 31, 2017

0.1 0.1
Additional paid-in capital 1,149.1 1,093.7
Accumulated other comprehensive loss (1.3 ) (2.6 )
Accumulated deficit   (665.8 )   (671.8 )
Total stockholders’ equity   482.1     419.4  
Total liabilities and stockholders’ equity $ 1,007.5   $ 904.1  
 
DexCom, Inc.
 
Consolidated Statements of Operations
(In millions—except per share data)
(Unaudited)
 
  Three Months Ended   Six Months Ended
June 30, June 30,
  2018       2017     2018       2017  
Revenues $ 242.5 $ 170.6 $ 426.9 $ 312.9
Cost of sales   88.9     53.1     154.4     101.3  
Gross profit 153.6 117.5 272.5 211.6
Operating expenses
Research and development 47.2 45.3 92.0 93.4
Selling, general and administrative   111.3     85.8     216.1     172.2  
Total operating expenses   158.5     131.1     308.1     265.6  
Operating loss (4.9 ) (13.6 ) (35.6 ) (54.0 )
Income from equity investments 42.7 50.1
Other income (expense) (5.6 ) 1.8 (3.0 ) 2.2
Interest income 2.2 0.5 3.7 0.7
Interest expense   (4.8 )   (3.1 )   (9.6 )   (3.6 )
Income (loss) before income taxes 29.6 (14.4 ) 5.6 (54.7 )
Income tax benefit   (0.6 )   (17.3 )   (0.4 )   (15.9 )
Net income (loss) $ 30.2   $ 2.9   $ 6.0   $ (38.8 )
Basic net income (loss) per share $ 0.34   $ 0.03   $ 0.07   $ (0.45 )
Shares used to compute basic net income (loss) per share   88.2     86.4     87.7     85.8  
Diluted net income (loss) per share $ 0.34   $ 0.03   $ 0.07   $ (0.45 )
Shares used to compute diluted net income (loss) per share   89.4     87.4    

88.8

    85.8  
 
DexCom, Inc.
 
Revenue by Geography
(In millions)
(Unaudited)
 
  Three Months Ended
June 30,
 

2018

 

   

2017

 

US revenue $ 189.6 $ 140.8
Year over year growth 35 % 18 %
% of total revenue 78 % 83 %
 
International revenue $ 52.9 $ 29.7
Year over year growth 78 % 69 %
% of total revenue 22 % 17 %
 
Total revenue(1) $ 242.5 $ 170.6
Year over year growth 42 % 24 %
 

(1) The sum of the revenue components may not equal total revenue due to rounding.

 
DexCom, Inc.
 
Revenue by Component
(In millions)

(Unaudited)

 
  Three Months Ended
June 30,
  2018      

2017(2)

 
Sensor & other revenue (3) (4) $ 179.4 $ 121.8
Year over year growth 47 % 27 %
% of total revenue 74 % 71 %
 
Transmitter revenue (3) $ 43.9 $ 34.9
Year over year growth 26 % 23 %
% of total revenue 18 % 20 %
 
Receiver revenue $ 19.1 $ 14.0
Year over year growth 36 % 7 %
% of total revenue 8 % 8 %
 
Total revenue (1) $ 242.5 $ 170.6
Year over year growth 42 % 24 %
 

(1) The sum of the revenue components may not equal total revenue due to rounding.

(2) Prior period reporting has been adjusted to conform to current component level reporting.

(3) Includes allocated subscription revenue.

(4) Includes services, freight, accessories, etc.

 
DexCom, Inc.
 
Itemized Reconciliation Between GAAP and Non-GAAP Net Income (Loss) and Net Income (Loss) per Share
(In millions—except per share data)
(Unaudited)
 
  Three Months Ended   Six Months Ended
June 30, June 30,
 

2017

 

2017

  2018  

(As Adjusted)(1)

  2018  

(As Adjusted)(1)

GAAP net income (loss) $ 30.2 $ 2.9 $ 6.0 $ (38.8 )
Non-cash interest expense (2) 3.3 1.8 6.6 1.8
Deferred tax benefit on senior convertible notes(3) (17.1 ) (17.1 )
Income from equity method investments (4) (42.7 ) (50.1 )
Tax effect of adjustments (5)                
Non-GAAP net loss $ (9.2 ) $ (12.4 ) $ (37.5 ) $ (54.1 )
 
GAAP basic and diluted net income (loss) per share $ 0.34 $ 0.03 $ 0.07 $ (0.45 )
Non-cash interest expense (2) 0.04 0.02 0.08 0.02
Deferred tax benefit on senior convertible notes(3) (0.20 ) (0.20 )
Income from equity method investments (4) (0.48 ) (0.57 )
Tax effect of adjustments (5)                
Non-GAAP basic and diluted net loss per share(6) $ (0.10 ) $ (0.14 ) $ (0.43 ) $ (0.63 )
 
Shares used to compute net income (loss) per share
Basic 88.2 86.4 87.7 85.8
Diluted 89.4 87.4

88.8

85.8
 

(1) The 2017 Non-GAAP presentation was adjusted to include non-cash interest expense to conform to 2018 presentation.

(2) Non-cash interest expense represents accretion of the debt discount associated with our 2022 Senior Convertible Notes.

(3) Non-cash tax benefit associated with the 2022 Senior Convertible Notes.

(4) Income from equity method investments is related to our investment in Tandem Diabetes Care, Inc.

(5) Tax-effecting GAAP only items at a 0% tax rate due to being in a position of recording a valuation allowance.

(6) Earnings per share amounts for the three months ended June 30, 2017 and the six months ended June 30, 2018 do not add due to rounding.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180801005864/en/

  • NVIDIA Soars in AI Market With New Platform & Partnerships
    Finance
    Zacks

    NVIDIA Soars in AI Market With New Platform & Partnerships

    NVIDIA Corporation’s NVDA efforts in artificial intelligence (AI) and machine learning in various fields are gathering momentum, thanks to its initiatives and adoption of its technologies by key companies.The past week has been quite eventful for NVIDIA

  • Sears bankruptcy could make these 5 big companies multi-million-dollar losers
    Finance
    Yahoo Finance

    Sears bankruptcy could make these 5 big companies multi-million-dollar losers

    Signs advertising store closing sales are seen on the doors of a Sears in New Hyde Park, New York, U.S., October 10, 2018. REUTERS/Shannon Stapleton Being an unsecured creditor of Sears (SHLD) right now is not a good place to be. The 125-year old former

  • Bank of America Earnings: Better Margins, Strong Asset Quality, and an All-Around Good Quarter
    Business
    Motley Fool

    Bank of America Earnings: Better Margins, Strong Asset Quality, and an All-Around Good Quarter

    Bank of America (NYSE: BAC) is the last of the "big four" U.S. banks to report its third-quarter earnings. Not only did Bank of America beat expectations on both the top and bottom lines, but the business looks pretty solid all around. First, looking at the top and bottom lines, Bank of America did quite well in the third quarter.

  • Better Buy: International Business Machines Corporation vs. McDonald's
    Business
    Motley Fool

    Better Buy: International Business Machines Corporation vs. McDonald's

    At first glance it may seem odd to compare International Business Machines (NYSE: IBM) and McDonald's (NYSE: MCD), as one company is a legacy tech giant and the other is the world's largest fast-food chain. McDonald's dates back to 1940, while IBM was founded in 1911. The two stocks also check many of the same boxes for investors, as they are both reliable dividend payers -- though only McDonald's is a Dividend Aristocrat, meaning it's raised its dividend every year for 25 years in a row.

  • Finance
    Bloomberg

    Tesla Skeptic Surprised by How Much He Enjoyed the Model 3

    In a broader note about positive electric-car momentum, Jonas said he observed workers at Tesla’s lone auto plant in Fremont, California, who were “extremely busy cranking out Model 3s” for delivery in the U.S. He also drove the dual-motor performance version of the vehicle, which he sees as having better value-for-performance than the Model S sedan. “Frankly, our enjoyment of the high-spec version of the Model 3 took us by surprise,” Jonas said, adding that it’s “hard to say how much this matters.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Business
    Motley Fool

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    One is market cap: Aurora's market cap is nearly 18 times bigger than Auxly's. Then there's stock performance. Here's how Aurora Cannabis and Auxly Cannabis Group stack up against each other in the areas that do matter.

  • This Is the Average American's Salary. How Does Yours Compare?
    Business
    Motley Fool

    This Is the Average American's Salary. How Does Yours Compare?

    In an age of oversharing, many of us are remarkably tight-lipped when it comes to talking salary. But in reality, knowing where you stand can help you determine whether you're in a good place or whether you should be taking steps to boost your earnings

  • Tesla Model 3 hits major milestone
    TSLA
    Fox Business Videos

    Tesla Model 3 hits major milestone

    FBN's Cheryl Casone on Tesla reaching a milestone of 100,000 Model 3 vehicles and Tesla CEO Elon Musk filing the paperwork to create a Tesla brand tequila called 'Teslaquila.'

  • Is This High-Flying Marijuana Stock the Next Tilray?
    Business
    Motley Fool

    Is This High-Flying Marijuana Stock the Next Tilray?

    Since then, Tilray's share price has skyrocketed to well over six times its opening-day level. At one point, Tilray was up a whopping 856% -- in just two months of trading. Now there's another marijuana stock that is beginning to turn heads.

  • Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession
    News
    Time

    Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession

    Prince Harry and Meghan Markle are expecting a baby in spring 2019, Kensington Palace announced Monday morning. Harry and Meghan married in May, becoming the Duke and Duchess of Sussex. Now, the question is where the new arrival will fit into the line of succession of the British royal family.

  • Icahn challenges Dell on planned deal with VMware
    Business
    American City Business Journals

    Icahn challenges Dell on planned deal with VMware

    Billionaire investor Carl Icahn confirmed that he upped his stake in shares that track Dell Technologies Inc.’s interest in VMware Inc. Through his company, Icahn Enterprises (NASDAQ: IEP), the octogenarian businessman owns 8.3 percent of VMware (NYSE: VMW). In a letter, Icahn said he plans to vote against Dell Technologies’ plan to buy the company — known by its ticker, DVMT — and encourage other shareholders to do the same. Silver Lake-owned Dell wants to ink a deal with VMware to streamline its ownership structure and return the company to the public markets as part of a complicated transaction worth $21.7 billion.

  • 2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better
    Business
    Motley Fool

    2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better

    During a tough week for the overall market, pharmaceutical stocks across the board fell a few notches despite a lack of significant news for the industry itself. Over the past five years, Pfizer has been able to raise its dividend 42% despite declining sales for aging blockbusters that lost patent protection and a sterile injectibles business that suffered major product shortages after it was acquired. Now that the worst is over, a strong product lineup and bulging pipeline could allow America's largest pharmaceutical company to direct a ton of cash toward its shareholders.

  • Ford Escape sales are down — here’s how it compares with other small SUVs
    Business
    American City Business Journals

    Ford Escape sales are down — here’s how it compares with other small SUVs

    Sales of the Ford Escape aren't what they used to be. The Escape, made at the Louisville Assembly Plant, saw sales decline by 20 percent in September 2018, compared with the same month last year. Ford and its Lincoln Motor Co. subsidiary have been successful in increasing sales of larger SUVs, such as the Navigator and Expedition this year.

  • Business
    Benzinga

    Bulls & Bears Of The Week: GE, Netflix, Nike, Twitter And More

    Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included an old-school conglomerate and a social media pair. Bearish calls included an electric car maker and a pharmaceutical firm. Another major hurricane

  • Microsoft Earnings: Mark Your Calendar
    Business
    Motley Fool

    Microsoft Earnings: Mark Your Calendar

    Software giant Microsoft (NASDAQ: MSFT) has continued to impress investors in 2018 amid its ongoing progress becoming a more cloud-centric company. Microsoft reports its first-quarter earnings for fiscal 2019 on October 24. Ahead of Microsoft's earnings release, here's an overview of some of the key areas investors will want to watch. Core to Microsoft's momentum recently is the company's rapidly growing commercial-cloud revenue.

  • Guess Who's Profiting From GE's Troubles?
    Business
    Motley Fool

    Guess Who's Profiting From GE's Troubles?

    One person's challenge is another's opportunity, and there are very few CEOs as bold and decisive in taking advantage of a chance to enhance value for shareholders as Emerson Electric's (NYSE: EMR) David Farr. Although the terms of Emerson's deal to buy General Electric's (NYSE: GE) Intelligent Platforms business weren't disclosed, it's likely that GE's desire to sell assets in order to raise cash means Farr's company wouldn't have overpaid to acquire a strategically important business. While the very-highly-regarded former Danaher CEO Larry Culp is now charged with turning around GE's fortunes, the executive with best recent experience in turning around a major industrial company is actually Emerson's David Farr.

  • Better Marijuana Stock: Canopy Growth Corporation vs. Aphria Inc.
    Business
    Motley Fool

    Better Marijuana Stock: Canopy Growth Corporation vs. Aphria Inc.

    Recreational marijuana sales begin on Oct. 17 in Canada, and investors convinced the program will be a hit have pushed shares of Canopy Growth Corporation (NYSE: CGC) and Aphria Inc. (NASDAQOTH: APHQF) up by 60% or better over the past few months. In just two short years, Canopy Growth Corporation's market cap has exploded from just $476 million two years ago to $10.1 billion at recent prices, and it looks like there could be more fireworks ahead. Canopy Growth has secured contracts that will require it to provide at least 67,000 kilograms of cannabis annually to Canadian provinces and territories.

  • Textron, NetJets strike aircraft deal for more than 300 p...
    TXT
    CNBC Videos

    Textron, NetJets strike aircraft deal for more than 300 p...

    CNBC's Phil LeBeau reports from the National Business Aviation Association annual convention on Textron and NetJets's new aircraft deal.

  • Why I’m Not Worried About Being Behind on Retirement Savings
    Business
    GoBankingRates

    Why I’m Not Worried About Being Behind on Retirement Savings

    This is why I find it funny that we spend most of our lives “retirement planning” or planning for our deaths. Don’t get me wrong, I’m not shouting in the face of retirement planning or being prepared. Although I’ve gotten my life back on track since then, I’m still not worried about being behind on retirement savings, the magical “$1 million saved” for retirement number or all the “what ifs.” Why?

  • 3 Top Small-Cap Stocks to Buy in October
    Business
    Motley Fool

    3 Top Small-Cap Stocks to Buy in October

    This fall, think small. To be more specific, think about buying small-cap stocks. Why? Small-cap stocks have the most growth potential. It's hard for a stock with a market cap of $500 billion to double. But it's a different story for stocks with market

  • Business
    Benzinga

    Insider Buys Of The Week: Conagra, Salesforce, Thor

    Conventional wisdom says insiders and 10 percent owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. While the board chair and other Salesforce.com, inc. (NYSE: CRM) executives have been selling throughout October, one director stepped up to the buy window this past week. The stock ended Friday at $146.74, down more than 4 percent for the week, and above the director's purchase price range.

  • Finance
    TheStreet.com

    Playing the Market Selloff: Is the S&P 500 a Buy or a Sell?

    The average earnings growth rate for the quarter so far is 19.1% (third highest growth rate since the first quarter of 2011). The forward 12-month P/E ratio for the S&P 500 is now 15.7x, compared to the five-year average of 16.3x.

  • Sears files for bankruptcy; Eddie Lampert steps down as CEO
    Business
    CNBC

    Sears files for bankruptcy; Eddie Lampert steps down as CEO

    Sears, once the largest U.S. retailer, has filed for bankruptcy. Eddie Lampert will be stepping down as CEO immediately, although he remains its chairman. As part of the bankruptcy, Sears will shutter 142 stores toward the end of the year.

  • It’s Official -- These 5 Social Security Changes Are Coming for 2019
    Business
    Motley Fool

    It’s Official -- These 5 Social Security Changes Are Coming for 2019

    For workers, Social Security's maximum taxable earnings are increasing, and more income will be required to earn a Social Security "credit." Beneficiaries who claimed Social Security early and still work will be happy to learn they'll be able to earn more without a benefit reduction in 2019, and for high earners, the maximum possible Social Security benefit is also on the rise. With all of that in mind, here are the recently released details of these five 2019 Social Security changes. As I mentioned, Social Security beneficiaries are getting a 2.8% COLA starting with their January 2019 benefit payment.

  • This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning
    Business
    Motley Fool

    This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning

    Investors have never been more excited about the prospects for marijuana stocks, and many of the best-known first movers in the industry call Canada their home. Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) is one of the major companies in the cannabis industry looking to cash in on the impending legalization of recreational marijuana in Canada, and it's put together an impressive set of resources designed to let it take maximum advantage of growing consumer interest in cannabis products. Like most up-and-coming companies, Aurora Cannabis isn't consistently profitable, and the marijuana producer is spending freely to ramp up its production capabilities to stay ahead of competitors.